|Series A, 9/2010 ||$1.4M|
|Series A, 8/2011 ||$3M|
|Private Equity, 12/2012 ||$3.23M|
Aura Biosciences, Inc. is applying nanotechnology to help fight cancer in the well-studied area of chemotherapeutics and the emerging field of RNAi. Auraâ€™s NanoSmart drug delivery system solves critical issues in drug delivery by encapsulating therapies within protein nanoparticles engineered for precise targeting, immune system evasion and efficient cellular uptake Aura combines the expertise of leading European and US research institutions with the flexibility and efficiency of a dedicated team of in-house scientists, deal-makers and world class advisors. The company is located in Cambridge, Massachusetts.